Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)
Clinical trial NCT04906694 · COMPLETED
Trial details
- NCT number
- NCT04906694
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2022-01-13
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.